nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE8A—myometrium—ovarian cancer	0.0183	0.0411	CbGeAlD
Ketotifen—PDE7A—female reproductive system—ovarian cancer	0.017	0.0383	CbGeAlD
Ketotifen—PDE8B—uterine cervix—ovarian cancer	0.0158	0.0356	CbGeAlD
Ketotifen—PDE8A—uterine cervix—ovarian cancer	0.0142	0.032	CbGeAlD
Ketotifen—PDE8A—decidua—ovarian cancer	0.0135	0.0305	CbGeAlD
Ketotifen—PDE8B—gonad—ovarian cancer	0.0132	0.0299	CbGeAlD
Ketotifen—PDE8B—uterus—ovarian cancer	0.0132	0.0297	CbGeAlD
Ketotifen—PDE8A—endometrium—ovarian cancer	0.0128	0.029	CbGeAlD
Ketotifen—PDE7B—testis—ovarian cancer	0.012	0.027	CbGeAlD
Ketotifen—PDE8A—uterus—ovarian cancer	0.0118	0.0267	CbGeAlD
Ketotifen—PDE8B—female reproductive system—ovarian cancer	0.0118	0.0267	CbGeAlD
Ketotifen—PGD—myometrium—ovarian cancer	0.0111	0.025	CbGeAlD
Ketotifen—PDE4A—decidua—ovarian cancer	0.0109	0.0245	CbGeAlD
Ketotifen—PDE8B—vagina—ovarian cancer	0.0107	0.0241	CbGeAlD
Ketotifen—PDE8A—female gonad—ovarian cancer	0.00969	0.0218	CbGeAlD
Ketotifen—PDE8A—vagina—ovarian cancer	0.00963	0.0217	CbGeAlD
Ketotifen—PDE8B—testis—ovarian cancer	0.00955	0.0215	CbGeAlD
Ketotifen—PDE4D—female gonad—ovarian cancer	0.00878	0.0198	CbGeAlD
Ketotifen—PDE7B—lymph node—ovarian cancer	0.00869	0.0196	CbGeAlD
Ketotifen—PGD—uterine cervix—ovarian cancer	0.00863	0.0195	CbGeAlD
Ketotifen—PDE8A—testis—ovarian cancer	0.00859	0.0194	CbGeAlD
Ketotifen—Tingling sensation—Melphalan—ovarian cancer	0.0085	0.0228	CcSEcCtD
Ketotifen—PGD—decidua—ovarian cancer	0.00823	0.0185	CbGeAlD
Ketotifen—PGD—endometrium—ovarian cancer	0.00781	0.0176	CbGeAlD
Ketotifen—PDE4D—testis—ovarian cancer	0.00778	0.0175	CbGeAlD
Ketotifen—PDE4A—female gonad—ovarian cancer	0.00777	0.0175	CbGeAlD
Ketotifen—Thrombocytopenia—Altretamine—ovarian cancer	0.0077	0.0207	CcSEcCtD
Ketotifen—Cystitis noninfective—Chlorambucil—ovarian cancer	0.00766	0.0205	CcSEcCtD
Ketotifen—Cystitis—Chlorambucil—ovarian cancer	0.00757	0.0203	CcSEcCtD
Ketotifen—PGD—gonad—ovarian cancer	0.00724	0.0163	CbGeAlD
Ketotifen—PGD—uterus—ovarian cancer	0.0072	0.0162	CbGeAlD
Ketotifen—Bladder pain—Chlorambucil—ovarian cancer	0.00709	0.019	CcSEcCtD
Ketotifen—PDE8B—lymph node—ovarian cancer	0.00692	0.0156	CbGeAlD
Ketotifen—PDE4A—testis—ovarian cancer	0.00689	0.0155	CbGeAlD
Ketotifen—PDE4B—uterine cervix—ovarian cancer	0.00679	0.0153	CbGeAlD
Ketotifen—Cystitis noninfective—Melphalan—ovarian cancer	0.00667	0.0179	CcSEcCtD
Ketotifen—Cystitis—Melphalan—ovarian cancer	0.0066	0.0177	CcSEcCtD
Ketotifen—PDE4B—decidua—ovarian cancer	0.00647	0.0146	CbGeAlD
Ketotifen—PGD—female reproductive system—ovarian cancer	0.00647	0.0146	CbGeAlD
Ketotifen—PDE8A—lymph node—ovarian cancer	0.00623	0.014	CbGeAlD
Ketotifen—Bladder pain—Melphalan—ovarian cancer	0.00618	0.0166	CcSEcCtD
Ketotifen—PDE4B—endometrium—ovarian cancer	0.00614	0.0138	CbGeAlD
Ketotifen—PGD—bone marrow—ovarian cancer	0.00611	0.0138	CbGeAlD
Ketotifen—PGD—female gonad—ovarian cancer	0.00589	0.0133	CbGeAlD
Ketotifen—PGD—vagina—ovarian cancer	0.00585	0.0132	CbGeAlD
Ketotifen—PDE4B—gonad—ovarian cancer	0.0057	0.0128	CbGeAlD
Ketotifen—Haematochezia—Epirubicin—ovarian cancer	0.0057	0.0153	CcSEcCtD
Ketotifen—PDE4D—lymph node—ovarian cancer	0.00564	0.0127	CbGeAlD
Ketotifen—Infection—Carboplatin—ovarian cancer	0.0054	0.0145	CcSEcCtD
Ketotifen—Haematochezia—Doxorubicin—ovarian cancer	0.00527	0.0141	CcSEcCtD
Ketotifen—PGD—testis—ovarian cancer	0.00522	0.0118	CbGeAlD
Ketotifen—Dizziness—Altretamine—ovarian cancer	0.0052	0.014	CcSEcCtD
Ketotifen—PDE4B—female reproductive system—ovarian cancer	0.00509	0.0115	CbGeAlD
Ketotifen—HRH1—myometrium—ovarian cancer	0.00502	0.0113	CbGeAlD
Ketotifen—Vomiting—Altretamine—ovarian cancer	0.005	0.0134	CcSEcCtD
Ketotifen—Tingling sensation—Paclitaxel—ovarian cancer	0.00499	0.0134	CcSEcCtD
Ketotifen—PDE4A—lymph node—ovarian cancer	0.00499	0.0113	CbGeAlD
Ketotifen—PDE4B—bone marrow—ovarian cancer	0.0048	0.0108	CbGeAlD
Ketotifen—Nausea—Altretamine—ovarian cancer	0.00467	0.0125	CcSEcCtD
Ketotifen—Pain—Carboplatin—ovarian cancer	0.00465	0.0125	CcSEcCtD
Ketotifen—PDE4B—female gonad—ovarian cancer	0.00463	0.0104	CbGeAlD
Ketotifen—PDE4B—vagina—ovarian cancer	0.0046	0.0104	CbGeAlD
Ketotifen—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00435	0.0117	CcSEcCtD
Ketotifen—Body temperature increased—Carboplatin—ovarian cancer	0.0043	0.0115	CcSEcCtD
Ketotifen—PDE4B—testis—ovarian cancer	0.00411	0.00926	CbGeAlD
Ketotifen—Weight increased—Topotecan—ovarian cancer	0.00398	0.0107	CcSEcCtD
Ketotifen—HRH1—epithelium—ovarian cancer	0.00394	0.00888	CbGeAlD
Ketotifen—HRH1—uterine cervix—ovarian cancer	0.00391	0.0088	CbGeAlD
Ketotifen—PGD—lymph node—ovarian cancer	0.00378	0.00853	CbGeAlD
Ketotifen—Erythema multiforme—Chlorambucil—ovarian cancer	0.00372	0.00998	CcSEcCtD
Ketotifen—HRH1—decidua—ovarian cancer	0.00372	0.00839	CbGeAlD
Ketotifen—Dry eye—Paclitaxel—ovarian cancer	0.00371	0.00994	CcSEcCtD
Ketotifen—Epistaxis—Topotecan—ovarian cancer	0.00368	0.00987	CcSEcCtD
Ketotifen—HRH1—endometrium—ovarian cancer	0.00353	0.00796	CbGeAlD
Ketotifen—Hepatitis—Melphalan—ovarian cancer	0.00343	0.0092	CcSEcCtD
Ketotifen—PDE4B—lymph node—ovarian cancer	0.00298	0.00671	CbGeAlD
Ketotifen—HRH1—female reproductive system—ovarian cancer	0.00293	0.0066	CbGeAlD
Ketotifen—Stinging—Epirubicin—ovarian cancer	0.00283	0.0076	CcSEcCtD
Ketotifen—Infection—Chlorambucil—ovarian cancer	0.00278	0.00745	CcSEcCtD
Ketotifen—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00274	0.00734	CcSEcCtD
Ketotifen—HRH1—female gonad—ovarian cancer	0.00266	0.006	CbGeAlD
Ketotifen—HRH1—vagina—ovarian cancer	0.00265	0.00596	CbGeAlD
Ketotifen—Stinging—Doxorubicin—ovarian cancer	0.00262	0.00703	CcSEcCtD
Ketotifen—Infection—Topotecan—ovarian cancer	0.00247	0.00663	CcSEcCtD
Ketotifen—Thrombocytopenia—Topotecan—ovarian cancer	0.00244	0.00654	CcSEcCtD
Ketotifen—Infection—Melphalan—ovarian cancer	0.00242	0.00649	CcSEcCtD
Ketotifen—Pain—Chlorambucil—ovarian cancer	0.00239	0.00641	CcSEcCtD
Ketotifen—Thrombocytopenia—Melphalan—ovarian cancer	0.00239	0.0064	CcSEcCtD
Ketotifen—HRH1—testis—ovarian cancer	0.00236	0.00532	CbGeAlD
Ketotifen—Weight increased—Paclitaxel—ovarian cancer	0.00229	0.00615	CcSEcCtD
Ketotifen—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00229	0.00613	CcSEcCtD
Ketotifen—Hypertension—Vinorelbine—ovarian cancer	0.00225	0.00604	CcSEcCtD
Ketotifen—Cystitis noninfective—Epirubicin—ovarian cancer	0.00224	0.00601	CcSEcCtD
Ketotifen—Paraesthesia—Topotecan—ovarian cancer	0.00224	0.00599	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00223	0.00597	CcSEcCtD
Ketotifen—Urticaria—Chlorambucil—ovarian cancer	0.00222	0.00596	CcSEcCtD
Ketotifen—Cystitis—Epirubicin—ovarian cancer	0.00222	0.00594	CcSEcCtD
Ketotifen—Body temperature increased—Chlorambucil—ovarian cancer	0.00221	0.00593	CcSEcCtD
Ketotifen—Abdominal pain—Chlorambucil—ovarian cancer	0.00221	0.00593	CcSEcCtD
Ketotifen—Paraesthesia—Melphalan—ovarian cancer	0.00219	0.00587	CcSEcCtD
Ketotifen—Pain—Topotecan—ovarian cancer	0.00213	0.00571	CcSEcCtD
Ketotifen—Dry eye—Epirubicin—ovarian cancer	0.00212	0.00569	CcSEcCtD
Ketotifen—Epistaxis—Paclitaxel—ovarian cancer	0.00212	0.00568	CcSEcCtD
Ketotifen—Infection—Vinorelbine—ovarian cancer	0.00212	0.00567	CcSEcCtD
Ketotifen—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00209	0.00559	CcSEcCtD
Ketotifen—Pain—Melphalan—ovarian cancer	0.00208	0.00559	CcSEcCtD
Ketotifen—Bladder pain—Epirubicin—ovarian cancer	0.00208	0.00557	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—ovarian cancer	0.00207	0.00556	CcSEcCtD
Ketotifen—Cystitis—Doxorubicin—ovarian cancer	0.00205	0.0055	CcSEcCtD
Ketotifen—Gastrointestinal pain—Topotecan—ovarian cancer	0.00204	0.00546	CcSEcCtD
Ketotifen—Pruritus—Chlorambucil—ovarian cancer	0.00198	0.00531	CcSEcCtD
Ketotifen—Urticaria—Topotecan—ovarian cancer	0.00198	0.0053	CcSEcCtD
Ketotifen—Abdominal pain—Topotecan—ovarian cancer	0.00197	0.00528	CcSEcCtD
Ketotifen—Body temperature increased—Topotecan—ovarian cancer	0.00197	0.00528	CcSEcCtD
Ketotifen—Dry eye—Doxorubicin—ovarian cancer	0.00196	0.00526	CcSEcCtD
Ketotifen—Weight increased—Docetaxel—ovarian cancer	0.00194	0.00521	CcSEcCtD
Ketotifen—Urticaria—Melphalan—ovarian cancer	0.00194	0.00519	CcSEcCtD
Ketotifen—Bladder pain—Doxorubicin—ovarian cancer	0.00192	0.00515	CcSEcCtD
Ketotifen—Diarrhoea—Chlorambucil—ovarian cancer	0.00191	0.00513	CcSEcCtD
Ketotifen—Paraesthesia—Vinorelbine—ovarian cancer	0.00191	0.00513	CcSEcCtD
Ketotifen—Erythema multiforme—Paclitaxel—ovarian cancer	0.00191	0.00511	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00189	0.00506	CcSEcCtD
Ketotifen—Pain—Vinorelbine—ovarian cancer	0.00182	0.00488	CcSEcCtD
Ketotifen—Epistaxis—Docetaxel—ovarian cancer	0.0018	0.00482	CcSEcCtD
Ketotifen—Vomiting—Chlorambucil—ovarian cancer	0.00178	0.00477	CcSEcCtD
Ketotifen—Increased appetite—Epirubicin—ovarian cancer	0.00177	0.00476	CcSEcCtD
Ketotifen—Pruritus—Topotecan—ovarian cancer	0.00176	0.00472	CcSEcCtD
Ketotifen—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00174	0.00467	CcSEcCtD
Ketotifen—Pruritus—Melphalan—ovarian cancer	0.00172	0.00463	CcSEcCtD
Ketotifen—Tension—Paclitaxel—ovarian cancer	0.00172	0.00462	CcSEcCtD
Ketotifen—HRH1—lymph node—ovarian cancer	0.00171	0.00386	CbGeAlD
Ketotifen—Hepatitis—Docetaxel—ovarian cancer	0.00171	0.00458	CcSEcCtD
Ketotifen—Nervousness—Paclitaxel—ovarian cancer	0.0017	0.00457	CcSEcCtD
Ketotifen—Diarrhoea—Topotecan—ovarian cancer	0.0017	0.00457	CcSEcCtD
Ketotifen—Urticaria—Vinorelbine—ovarian cancer	0.00169	0.00454	CcSEcCtD
Ketotifen—Abdominal pain—Vinorelbine—ovarian cancer	0.00168	0.00451	CcSEcCtD
Ketotifen—Body temperature increased—Vinorelbine—ovarian cancer	0.00168	0.00451	CcSEcCtD
Ketotifen—Diarrhoea—Melphalan—ovarian cancer	0.00167	0.00447	CcSEcCtD
Ketotifen—Nausea—Chlorambucil—ovarian cancer	0.00166	0.00445	CcSEcCtD
Ketotifen—Dizziness—Topotecan—ovarian cancer	0.00165	0.00441	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—ovarian cancer	0.00164	0.0044	CcSEcCtD
Ketotifen—Erythema multiforme—Docetaxel—ovarian cancer	0.00162	0.00433	CcSEcCtD
Ketotifen—Vomiting—Topotecan—ovarian cancer	0.00158	0.00424	CcSEcCtD
Ketotifen—Syncope—Paclitaxel—ovarian cancer	0.00157	0.00422	CcSEcCtD
Ketotifen—Rash—Topotecan—ovarian cancer	0.00157	0.00421	CcSEcCtD
Ketotifen—Dermatitis—Topotecan—ovarian cancer	0.00157	0.00421	CcSEcCtD
Ketotifen—Headache—Topotecan—ovarian cancer	0.00156	0.00418	CcSEcCtD
Ketotifen—Vomiting—Melphalan—ovarian cancer	0.00155	0.00416	CcSEcCtD
Ketotifen—Loss of consciousness—Paclitaxel—ovarian cancer	0.00154	0.00414	CcSEcCtD
Ketotifen—Rash—Melphalan—ovarian cancer	0.00154	0.00412	CcSEcCtD
Ketotifen—Dermatitis—Melphalan—ovarian cancer	0.00154	0.00412	CcSEcCtD
Ketotifen—Hypertension—Paclitaxel—ovarian cancer	0.00152	0.00406	CcSEcCtD
Ketotifen—Pruritus—Vinorelbine—ovarian cancer	0.00151	0.00404	CcSEcCtD
Ketotifen—Nausea—Topotecan—ovarian cancer	0.00148	0.00397	CcSEcCtD
Ketotifen—Dry mouth—Paclitaxel—ovarian cancer	0.00146	0.00392	CcSEcCtD
Ketotifen—Diarrhoea—Vinorelbine—ovarian cancer	0.00146	0.00391	CcSEcCtD
Ketotifen—Nausea—Melphalan—ovarian cancer	0.00145	0.00388	CcSEcCtD
Ketotifen—Infection—Paclitaxel—ovarian cancer	0.00142	0.00382	CcSEcCtD
Ketotifen—Shock—Paclitaxel—ovarian cancer	0.00141	0.00378	CcSEcCtD
Ketotifen—Dizziness—Vinorelbine—ovarian cancer	0.00141	0.00378	CcSEcCtD
Ketotifen—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0014	0.00376	CcSEcCtD
Ketotifen—Vomiting—Vinorelbine—ovarian cancer	0.00135	0.00363	CcSEcCtD
Ketotifen—Rash—Vinorelbine—ovarian cancer	0.00134	0.0036	CcSEcCtD
Ketotifen—Dermatitis—Vinorelbine—ovarian cancer	0.00134	0.0036	CcSEcCtD
Ketotifen—Headache—Vinorelbine—ovarian cancer	0.00133	0.00358	CcSEcCtD
Ketotifen—Syncope—Docetaxel—ovarian cancer	0.00133	0.00358	CcSEcCtD
Ketotifen—Weight increased—Epirubicin—ovarian cancer	0.00131	0.00351	CcSEcCtD
Ketotifen—Loss of consciousness—Docetaxel—ovarian cancer	0.00131	0.00351	CcSEcCtD
Ketotifen—Insomnia—Paclitaxel—ovarian cancer	0.0013	0.00347	CcSEcCtD
Ketotifen—Paraesthesia—Paclitaxel—ovarian cancer	0.00129	0.00345	CcSEcCtD
Ketotifen—Hypertension—Docetaxel—ovarian cancer	0.00128	0.00344	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—ovarian cancer	0.00128	0.00344	CcSEcCtD
Ketotifen—Somnolence—Paclitaxel—ovarian cancer	0.00127	0.00342	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00127	0.00341	CcSEcCtD
Ketotifen—Nausea—Vinorelbine—ovarian cancer	0.00126	0.00339	CcSEcCtD
Ketotifen—Dry mouth—Docetaxel—ovarian cancer	0.00124	0.00332	CcSEcCtD
Ketotifen—Pain—Paclitaxel—ovarian cancer	0.00122	0.00329	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—ovarian cancer	0.00121	0.00325	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—ovarian cancer	0.00121	0.00325	CcSEcCtD
Ketotifen—Infection—Docetaxel—ovarian cancer	0.00121	0.00323	CcSEcCtD
Ketotifen—Shock—Docetaxel—ovarian cancer	0.00119	0.0032	CcSEcCtD
Ketotifen—Thrombocytopenia—Docetaxel—ovarian cancer	0.00119	0.00319	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—ovarian cancer	0.00119	0.00319	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00118	0.00316	CcSEcCtD
Ketotifen—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00117	0.00314	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—ovarian cancer	0.00115	0.00309	CcSEcCtD
Ketotifen—Urticaria—Paclitaxel—ovarian cancer	0.00114	0.00305	CcSEcCtD
Ketotifen—Abdominal pain—Paclitaxel—ovarian cancer	0.00113	0.00304	CcSEcCtD
Ketotifen—Body temperature increased—Paclitaxel—ovarian cancer	0.00113	0.00304	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—ovarian cancer	0.00112	0.00301	CcSEcCtD
Ketotifen—Insomnia—Docetaxel—ovarian cancer	0.0011	0.00294	CcSEcCtD
Ketotifen—Paraesthesia—Docetaxel—ovarian cancer	0.00109	0.00292	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—ovarian cancer	0.00109	0.00292	CcSEcCtD
Ketotifen—Somnolence—Docetaxel—ovarian cancer	0.00108	0.00289	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—ovarian cancer	0.00107	0.00286	CcSEcCtD
Ketotifen—Pain—Docetaxel—ovarian cancer	0.00104	0.00278	CcSEcCtD
Ketotifen—Pruritus—Paclitaxel—ovarian cancer	0.00101	0.00272	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—ovarian cancer	0.00101	0.0027	CcSEcCtD
Ketotifen—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000993	0.00266	CcSEcCtD
Ketotifen—Tension—Epirubicin—ovarian cancer	0.000985	0.00264	CcSEcCtD
Ketotifen—Diarrhoea—Paclitaxel—ovarian cancer	0.00098	0.00263	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—ovarian cancer	0.000975	0.00261	CcSEcCtD
Ketotifen—Body temperature increased—Docetaxel—ovarian cancer	0.00096	0.00257	CcSEcCtD
Ketotifen—Abdominal pain—Docetaxel—ovarian cancer	0.00096	0.00257	CcSEcCtD
Ketotifen—Dizziness—Paclitaxel—ovarian cancer	0.000947	0.00254	CcSEcCtD
Ketotifen—Tension—Doxorubicin—ovarian cancer	0.000911	0.00244	CcSEcCtD
Ketotifen—Vomiting—Paclitaxel—ovarian cancer	0.000911	0.00244	CcSEcCtD
Ketotifen—Rash—Paclitaxel—ovarian cancer	0.000903	0.00242	CcSEcCtD
Ketotifen—Dermatitis—Paclitaxel—ovarian cancer	0.000902	0.00242	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—ovarian cancer	0.000902	0.00242	CcSEcCtD
Ketotifen—Syncope—Epirubicin—ovarian cancer	0.0009	0.00241	CcSEcCtD
Ketotifen—Headache—Paclitaxel—ovarian cancer	0.000897	0.00241	CcSEcCtD
Ketotifen—Loss of consciousness—Epirubicin—ovarian cancer	0.000882	0.00237	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—ovarian cancer	0.000866	0.00232	CcSEcCtD
Ketotifen—Pruritus—Docetaxel—ovarian cancer	0.000859	0.0023	CcSEcCtD
Ketotifen—Nausea—Paclitaxel—ovarian cancer	0.000851	0.00228	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—ovarian cancer	0.000835	0.00224	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—ovarian cancer	0.000833	0.00223	CcSEcCtD
Ketotifen—Diarrhoea—Docetaxel—ovarian cancer	0.000831	0.00223	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—ovarian cancer	0.000816	0.00219	CcSEcCtD
Ketotifen—Infection—Epirubicin—ovarian cancer	0.000814	0.00218	CcSEcCtD
Ketotifen—Shock—Epirubicin—ovarian cancer	0.000806	0.00216	CcSEcCtD
Ketotifen—Dizziness—Docetaxel—ovarian cancer	0.000803	0.00215	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—ovarian cancer	0.000802	0.00215	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—ovarian cancer	0.000802	0.00215	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—ovarian cancer	0.000773	0.00207	CcSEcCtD
Ketotifen—Vomiting—Docetaxel—ovarian cancer	0.000772	0.00207	CcSEcCtD
Ketotifen—Rash—Docetaxel—ovarian cancer	0.000766	0.00205	CcSEcCtD
Ketotifen—Dermatitis—Docetaxel—ovarian cancer	0.000765	0.00205	CcSEcCtD
Ketotifen—Headache—Docetaxel—ovarian cancer	0.000761	0.00204	CcSEcCtD
Ketotifen—Infection—Doxorubicin—ovarian cancer	0.000753	0.00202	CcSEcCtD
Ketotifen—Shock—Doxorubicin—ovarian cancer	0.000745	0.002	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000742	0.00199	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—ovarian cancer	0.000741	0.00199	CcSEcCtD
Ketotifen—Paraesthesia—Epirubicin—ovarian cancer	0.000735	0.00197	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—ovarian cancer	0.000728	0.00195	CcSEcCtD
Ketotifen—Nausea—Docetaxel—ovarian cancer	0.000721	0.00193	CcSEcCtD
Ketotifen—Pain—Epirubicin—ovarian cancer	0.0007	0.00188	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—ovarian cancer	0.000685	0.00184	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—ovarian cancer	0.00068	0.00182	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—ovarian cancer	0.000674	0.00181	CcSEcCtD
Ketotifen—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00067	0.0018	CcSEcCtD
Ketotifen—Urticaria—Epirubicin—ovarian cancer	0.000651	0.00174	CcSEcCtD
Ketotifen—Pain—Doxorubicin—ovarian cancer	0.000648	0.00174	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—ovarian cancer	0.000647	0.00174	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—ovarian cancer	0.000647	0.00174	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00062	0.00166	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—ovarian cancer	0.000602	0.00161	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—ovarian cancer	0.000599	0.00161	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—ovarian cancer	0.000599	0.00161	CcSEcCtD
Ketotifen—Pruritus—Epirubicin—ovarian cancer	0.000579	0.00155	CcSEcCtD
Ketotifen—Diarrhoea—Epirubicin—ovarian cancer	0.00056	0.0015	CcSEcCtD
Ketotifen—Dizziness—Epirubicin—ovarian cancer	0.000542	0.00145	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—ovarian cancer	0.000536	0.00144	CcSEcCtD
Ketotifen—Vomiting—Epirubicin—ovarian cancer	0.000521	0.0014	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—ovarian cancer	0.000518	0.00139	CcSEcCtD
Ketotifen—Rash—Epirubicin—ovarian cancer	0.000516	0.00138	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—ovarian cancer	0.000516	0.00138	CcSEcCtD
Ketotifen—Headache—Epirubicin—ovarian cancer	0.000513	0.00138	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—ovarian cancer	0.000501	0.00134	CcSEcCtD
Ketotifen—Nausea—Epirubicin—ovarian cancer	0.000486	0.0013	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—ovarian cancer	0.000482	0.00129	CcSEcCtD
Ketotifen—Rash—Doxorubicin—ovarian cancer	0.000478	0.00128	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—ovarian cancer	0.000477	0.00128	CcSEcCtD
Ketotifen—Headache—Doxorubicin—ovarian cancer	0.000475	0.00127	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—ovarian cancer	0.00045	0.00121	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—MAPK1—ovarian cancer	8.52e-05	0.000465	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—EGFR—ovarian cancer	8.52e-05	0.000465	CbGpPWpGaD
Ketotifen—PGD—Disease—PIK3CA—ovarian cancer	8.44e-05	0.00046	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CD—ovarian cancer	8.43e-05	0.00046	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ESR1—ovarian cancer	8.41e-05	0.000458	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—PIK3CA—ovarian cancer	8.35e-05	0.000455	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—APC—ovarian cancer	8.35e-05	0.000455	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CG—ovarian cancer	8.35e-05	0.000455	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—NRAS—ovarian cancer	8.35e-05	0.000455	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MAPK3—ovarian cancer	8.33e-05	0.000454	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PIK3CA—ovarian cancer	8.3e-05	0.000452	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PIK3CA—ovarian cancer	8.3e-05	0.000452	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6ST—ovarian cancer	8.27e-05	0.000451	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—KRAS—ovarian cancer	8.25e-05	0.00045	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HDAC6—ovarian cancer	8.12e-05	0.000443	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MYC—ovarian cancer	8.1e-05	0.000442	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CAV1—ovarian cancer	8.07e-05	0.00044	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—KRAS—ovarian cancer	8.05e-05	0.000439	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—ovarian cancer	8.03e-05	0.000438	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—ovarian cancer	8.03e-05	0.000438	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PPP2R1A—ovarian cancer	8.01e-05	0.000437	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	8.01e-05	0.000437	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—MAPK3—ovarian cancer	8e-05	0.000436	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—APC—ovarian cancer	7.95e-05	0.000433	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CG—ovarian cancer	7.95e-05	0.000433	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—NRAS—ovarian cancer	7.95e-05	0.000433	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MAPK1—ovarian cancer	7.92e-05	0.000432	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—EGFR—ovarian cancer	7.92e-05	0.000432	CbGpPWpGaD
Ketotifen—PGD—Disease—HRAS—ovarian cancer	7.81e-05	0.000426	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ESR1—ovarian cancer	7.78e-05	0.000424	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CXCL8—ovarian cancer	7.7e-05	0.00042	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—HRAS—ovarian cancer	7.68e-05	0.000419	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—HRAS—ovarian cancer	7.68e-05	0.000419	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	7.67e-05	0.000418	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6ST—ovarian cancer	7.65e-05	0.000417	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—MAPK3—ovarian cancer	7.61e-05	0.000415	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—MAPK1—ovarian cancer	7.61e-05	0.000415	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—EGFR—ovarian cancer	7.61e-05	0.000415	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PIK3CA—ovarian cancer	7.58e-05	0.000413	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—KRAS—ovarian cancer	7.48e-05	0.000408	CbGpPWpGaD
Ketotifen—PGD—Disease—IL6—ovarian cancer	7.48e-05	0.000408	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—ERBB2—ovarian cancer	7.45e-05	0.000406	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PIK3CA—ovarian cancer	7.39e-05	0.000403	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CG—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—APC—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—NRAS—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CB—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MTOR—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL6—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL6—ovarian cancer	7.35e-05	0.000401	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CD—ovarian cancer	7.34e-05	0.0004	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PIK3CA—ovarian cancer	7.27e-05	0.000396	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—MAPK1—ovarian cancer	7.24e-05	0.000395	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—EGFR—ovarian cancer	7.24e-05	0.000395	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—YAP1—ovarian cancer	7.19e-05	0.000392	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—ovarian cancer	7.19e-05	0.000392	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—ovarian cancer	7.15e-05	0.00039	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PIK3CA—ovarian cancer	7.07e-05	0.000385	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCL8—ovarian cancer	7.06e-05	0.000385	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—XIAP—ovarian cancer	7.04e-05	0.000384	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—MAPK3—ovarian cancer	7.04e-05	0.000384	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—HRAS—ovarian cancer	7.02e-05	0.000383	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CD—ovarian cancer	6.99e-05	0.000381	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PIK3CA—ovarian cancer	6.92e-05	0.000377	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1B—ovarian cancer	6.9e-05	0.000376	CbGpPWpGaD
Ketotifen—PGD—Disease—AKT1—ovarian cancer	6.9e-05	0.000376	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PIK3CA—ovarian cancer	6.87e-05	0.000375	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMARCA4—ovarian cancer	6.86e-05	0.000374	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—HRAS—ovarian cancer	6.84e-05	0.000373	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—ovarian cancer	6.84e-05	0.000373	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—AKT1—ovarian cancer	6.82e-05	0.000372	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—AKT1—ovarian cancer	6.78e-05	0.00037	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—AKT1—ovarian cancer	6.78e-05	0.00037	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CASP3—ovarian cancer	6.76e-05	0.000369	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL2—ovarian cancer	6.75e-05	0.000368	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL6—ovarian cancer	6.72e-05	0.000366	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—MAPK1—ovarian cancer	6.7e-05	0.000365	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—EGFR—ovarian cancer	6.7e-05	0.000365	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EREG—ovarian cancer	6.7e-05	0.000365	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—ovarian cancer	6.65e-05	0.000363	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PIK3CA—ovarian cancer	6.6e-05	0.00036	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCND1—ovarian cancer	6.58e-05	0.000359	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL6—ovarian cancer	6.55e-05	0.000357	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—ovarian cancer	6.52e-05	0.000355	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ERBB2—ovarian cancer	6.48e-05	0.000353	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CD—ovarian cancer	6.46e-05	0.000352	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—ovarian cancer	6.4e-05	0.000349	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MTOR—ovarian cancer	6.4e-05	0.000349	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CB—ovarian cancer	6.4e-05	0.000349	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MMP9—ovarian cancer	6.39e-05	0.000348	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—HRAS—ovarian cancer	6.36e-05	0.000347	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—ovarian cancer	6.35e-05	0.000346	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—ovarian cancer	6.33e-05	0.000345	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—ovarian cancer	6.28e-05	0.000343	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PGR—ovarian cancer	6.28e-05	0.000342	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—AKT1—ovarian cancer	6.2e-05	0.000338	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ERBB2—ovarian cancer	6.17e-05	0.000336	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL8—ovarian cancer	6.15e-05	0.000335	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—HRAS—ovarian cancer	6.11e-05	0.000333	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CB—ovarian cancer	6.09e-05	0.000332	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MTOR—ovarian cancer	6.09e-05	0.000332	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL6—ovarian cancer	6.09e-05	0.000332	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—AKT1—ovarian cancer	6.04e-05	0.000329	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1B—ovarian cancer	6e-05	0.000327	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—AKT1—ovarian cancer	5.94e-05	0.000324	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CG—ovarian cancer	5.91e-05	0.000322	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CASP3—ovarian cancer	5.88e-05	0.000321	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL2—ovarian cancer	5.88e-05	0.00032	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL8—ovarian cancer	5.85e-05	0.000319	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL6—ovarian cancer	5.85e-05	0.000319	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PARP1—ovarian cancer	5.84e-05	0.000318	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—ovarian cancer	5.81e-05	0.000317	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—HRAS—ovarian cancer	5.81e-05	0.000317	CbGpPWpGaD
Ketotifen—PGD—Metabolism—AKT1—ovarian cancer	5.78e-05	0.000315	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—ovarian cancer	5.74e-05	0.000313	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCND1—ovarian cancer	5.73e-05	0.000312	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1B—ovarian cancer	5.71e-05	0.000312	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ERBB2—ovarian cancer	5.71e-05	0.000311	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—STAT3—ovarian cancer	5.68e-05	0.00031	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—ovarian cancer	5.67e-05	0.000309	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—NRAS—ovarian cancer	5.67e-05	0.000309	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—AKT1—ovarian cancer	5.65e-05	0.000308	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MTOR—ovarian cancer	5.63e-05	0.000307	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CB—ovarian cancer	5.63e-05	0.000307	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—AKT1—ovarian cancer	5.62e-05	0.000306	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CASP3—ovarian cancer	5.6e-05	0.000305	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL2—ovarian cancer	5.59e-05	0.000305	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6ST—ovarian cancer	5.58e-05	0.000304	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL6—ovarian cancer	5.56e-05	0.000303	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MMP9—ovarian cancer	5.56e-05	0.000303	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—ovarian cancer	5.53e-05	0.000301	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCND1—ovarian cancer	5.45e-05	0.000297	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK3—ovarian cancer	5.43e-05	0.000296	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL8—ovarian cancer	5.41e-05	0.000295	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—ovarian cancer	5.4e-05	0.000294	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—AKT1—ovarian cancer	5.39e-05	0.000294	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—HRAS—ovarian cancer	5.38e-05	0.000293	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CG—ovarian cancer	5.36e-05	0.000292	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MMP9—ovarian cancer	5.29e-05	0.000289	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1B—ovarian cancer	5.29e-05	0.000288	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MYC—ovarian cancer	5.28e-05	0.000288	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—ovarian cancer	5.26e-05	0.000287	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—AKT1—ovarian cancer	5.23e-05	0.000285	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CD—ovarian cancer	5.19e-05	0.000283	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CASP3—ovarian cancer	5.18e-05	0.000283	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL2—ovarian cancer	5.17e-05	0.000282	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK1—ovarian cancer	5.16e-05	0.000281	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EGFR—ovarian cancer	5.16e-05	0.000281	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL6—ovarian cancer	5.15e-05	0.000281	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—AKT1—ovarian cancer	5.13e-05	0.00028	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCND1—ovarian cancer	5.04e-05	0.000275	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—ovarian cancer	5e-05	0.000272	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—ovarian cancer	4.99e-05	0.000272	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—STAT3—ovarian cancer	4.94e-05	0.00027	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NRAS—ovarian cancer	4.93e-05	0.000269	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MMP9—ovarian cancer	4.9e-05	0.000267	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—ovarian cancer	4.88e-05	0.000266	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—ovarian cancer	4.87e-05	0.000265	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—ovarian cancer	4.75e-05	0.000259	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	4.75e-05	0.000259	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PPP2R1A—ovarian cancer	4.73e-05	0.000258	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK3—ovarian cancer	4.72e-05	0.000258	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CD—ovarian cancer	4.72e-05	0.000257	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—STAT3—ovarian cancer	4.71e-05	0.000257	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NRAS—ovarian cancer	4.69e-05	0.000256	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MYC—ovarian cancer	4.59e-05	0.00025	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CB—ovarian cancer	4.53e-05	0.000247	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK3—ovarian cancer	4.5e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK1—ovarian cancer	4.49e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGFR—ovarian cancer	4.49e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—ovarian cancer	4.48e-05	0.000244	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	4.4e-05	0.00024	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MYC—ovarian cancer	4.37e-05	0.000238	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—STAT3—ovarian cancer	4.35e-05	0.000237	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL8—ovarian cancer	4.35e-05	0.000237	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NRAS—ovarian cancer	4.34e-05	0.000237	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—ovarian cancer	4.33e-05	0.000236	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK1—ovarian cancer	4.28e-05	0.000233	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGFR—ovarian cancer	4.28e-05	0.000233	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—ovarian cancer	4.25e-05	0.000231	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	4.16e-05	0.000227	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL2—ovarian cancer	4.16e-05	0.000227	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HRAS—ovarian cancer	4.14e-05	0.000226	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CB—ovarian cancer	4.11e-05	0.000224	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MYC—ovarian cancer	4.05e-05	0.000221	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—ovarian cancer	4.04e-05	0.00022	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL6—ovarian cancer	3.97e-05	0.000216	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	3.96e-05	0.000216	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGFR—ovarian cancer	3.96e-05	0.000216	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL8—ovarian cancer	3.95e-05	0.000215	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—ovarian cancer	3.9e-05	0.000213	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL2—ovarian cancer	3.77e-05	0.000206	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—ovarian cancer	3.77e-05	0.000206	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TERT—ovarian cancer	3.76e-05	0.000205	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—ovarian cancer	3.74e-05	0.000204	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—ovarian cancer	3.71e-05	0.000202	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—AKT1—ovarian cancer	3.66e-05	0.0002	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HRAS—ovarian cancer	3.61e-05	0.000197	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—ovarian cancer	3.59e-05	0.000196	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CAV1—ovarian cancer	3.48e-05	0.00019	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL6—ovarian cancer	3.45e-05	0.000188	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	3.43e-05	0.000187	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HRAS—ovarian cancer	3.43e-05	0.000187	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ESR1—ovarian cancer	3.35e-05	0.000183	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—ovarian cancer	3.32e-05	0.000181	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6ST—ovarian cancer	3.3e-05	0.00018	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6—ovarian cancer	3.29e-05	0.000179	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—AKT1—ovarian cancer	3.19e-05	0.000174	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HRAS—ovarian cancer	3.18e-05	0.000173	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CG—ovarian cancer	3.17e-05	0.000173	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—APC—ovarian cancer	3.17e-05	0.000173	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—NRAS—ovarian cancer	3.17e-05	0.000173	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6—ovarian cancer	3.04e-05	0.000166	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAPK3—ovarian cancer	3.03e-05	0.000165	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—AKT1—ovarian cancer	3.03e-05	0.000165	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAPK1—ovarian cancer	2.89e-05	0.000157	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—EGFR—ovarian cancer	2.89e-05	0.000157	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—AKT1—ovarian cancer	2.81e-05	0.000153	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CD—ovarian cancer	2.79e-05	0.000152	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—ovarian cancer	2.76e-05	0.00015	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—ovarian cancer	2.73e-05	0.000149	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—ovarian cancer	2.51e-05	0.000137	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB2—ovarian cancer	2.46e-05	0.000134	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MTOR—ovarian cancer	2.43e-05	0.000132	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CB—ovarian cancer	2.43e-05	0.000132	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL8—ovarian cancer	2.33e-05	0.000127	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—HRAS—ovarian cancer	2.32e-05	0.000126	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	2.28e-05	0.000124	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	2.25e-05	0.000123	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP3—ovarian cancer	2.23e-05	0.000122	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL2—ovarian cancer	2.23e-05	0.000122	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6—ovarian cancer	2.22e-05	0.000121	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCND1—ovarian cancer	2.17e-05	0.000119	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	2.15e-05	0.000117	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP9—ovarian cancer	2.11e-05	0.000115	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—ovarian cancer	2.1e-05	0.000114	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT1—ovarian cancer	2.05e-05	0.000112	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—ovarian cancer	1.89e-05	0.000103	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STAT3—ovarian cancer	1.88e-05	0.000102	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRAS—ovarian cancer	1.87e-05	0.000102	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK3—ovarian cancer	1.79e-05	9.77e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MYC—ovarian cancer	1.74e-05	9.51e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK1—ovarian cancer	1.71e-05	9.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGFR—ovarian cancer	1.71e-05	9.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—ovarian cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	1.48e-05	8.07e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—ovarian cancer	1.43e-05	7.81e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HRAS—ovarian cancer	1.37e-05	7.47e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6—ovarian cancer	1.31e-05	7.15e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT1—ovarian cancer	1.21e-05	6.59e-05	CbGpPWpGaD
